AAAAAA

   
Results: 1-20 |

Table of contents of journal:

Results: 20

Authors: Edelman, R
Citation: R. Edelman, An overview of adjuvant use, METH MOL M, 42, 2000, pp. 1-27

Authors: Stewart-Tull, DES
Citation: Des. Stewart-tull, Harmful and beneficial activities of immunological adjuvants, METH MOL M, 42, 2000, pp. 29-48

Authors: Lindblad, EB
Citation: Eb. Lindblad, Freund's adjuvants, METH MOL M, 42, 2000, pp. 49-63

Authors: Gupta, RK Rost, BE
Citation: Rk. Gupta et Be. Rost, Aluminum compounds as vaccine adjuvants, METH MOL M, 42, 2000, pp. 65-89

Authors: O'Hagan, DT Singh, M
Citation: Dt. O'Hagan et M. Singh, Poly(lactide-coglycolide) microparticles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 91-103

Authors: Kreuter, J
Citation: J. Kreuter, Poly(methyl methacrylate) nanoparticles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 105-119

Authors: Todd, CW Newman, MJ
Citation: Cw. Todd et Mj. Newman, Aqueous formulation of adjuvant-active nonionic block copolymers, METH MOL M, 42, 2000, pp. 121-136

Authors: Gregoriadis, G McCormack, B Obrenovic, M Perrie, Y Saffie, R
Citation: G. Gregoriadis et al., Liposomes as immunological adjuvants and vaccine carriers, METH MOL M, 42, 2000, pp. 137-150

Authors: Gluck, R
Citation: R. Gluck, Immunopotentiating reconstituted influenza virosomes (IRIVs), METH MOL M, 42, 2000, pp. 151-178

Authors: Gould-Fogerite, S Mannino, RJ
Citation: S. Gould-fogerite et Rj. Mannino, Cochleates for induction of mucosal and systemic immune responses, METH MOL M, 42, 2000, pp. 179-196

Authors: Gilbert, SC
Citation: Sc. Gilbert, Virus-like particles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 197-209

Authors: Ott, G Radhakrishnan, R Fang, JH Hora, M
Citation: G. Ott et al., The adjuvant MF59: A 10-year perspective, METH MOL M, 42, 2000, pp. 211-228

Authors: Lidgate, DM
Citation: Dm. Lidgate, Preparation of the Syntex adjuvant formulation (SAF, SAF-m, SAF-1), METH MOL M, 42, 2000, pp. 229-237

Authors: Lovgren-Bengtsson, K Morein, B
Citation: K. Lovgren-bengtsson et B. Morein, The ISCOM (TM) technology, METH MOL M, 42, 2000, pp. 239-258

Authors: Kensil, CR
Citation: Cr. Kensil, QS-21 adjuvant, METH MOL M, 42, 2000, pp. 259-271

Authors: Ulrich, JT
Citation: Jt. Ulrich, MPL (R) immunostimulant: Adjuvant formulations, METH MOL M, 42, 2000, pp. 273-282

Authors: Giedlin, MA
Citation: Ma. Giedlin, Cytokines as vaccine adjuvants: The use of interleukin-2, METH MOL M, 42, 2000, pp. 283-297

Authors: Neujahr, DC Pisetsky, DS
Citation: Dc. Neujahr et Ds. Pisetsky, DNA as an adjuvant, METH MOL M, 42, 2000, pp. 299-313

Authors: Glenn, GM Scharton-Kersten, T Vassell, R
Citation: Gm. Glenn et al., Transcutaneous immunization, METH MOL M, 42, 2000, pp. 315-326

Authors: Neidleman, JA Ott, G O'Hagan, D
Citation: Ja. Neidleman et al., Mutant heat-labile enterotoxins as adjuvants for CTL induction, METH MOL M, 42, 2000, pp. 327-336
Risultati: 1-20 |